Park Hyeon-joo is a visionary entrepreneur and trailblazer in the financial industry. In 1997, he founded Mirae Asset Investment Advisory, along with its venture capital affiliate, marking the beginning of his remarkable journey. Recognized as the driving force behind South Korea's mutual fund sector, Park Hyeon-joo introduced the nation's first closed-end mutual fund in 1998, setting a new standard for innovation. With his leadership, his firm has expanded its reach to 12 countries, managing an impressive portfolio of approximately $190 billion in assets. Hyeon-Joo Park has directed investments towards cancer vaccine companies, such as Crossbow Therapeutics and Aston Sci, underlining a commitment to advancing cancer treatment and research.